INTRACEL CORP
RW, 1999-03-03
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: INTRACEL CORP, RW, 1999-03-03
Next: MILLION DOLLAR SALOON INC, 10KSB, 1999-03-03



<PAGE>   1
                      [letterhead of Intracel Corporation]


                                  March 3, 1999


VIA EDGAR AND FACSIMILE

Mr. Jeffrey P. Riedler
Division of Corporation Finance
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

        Re: Intracel Corporation
            Request to Withdraw Registration Statement on Form 8-A, as amended.
            File No. 000-25363

Ladies and Gentlemen:

        Intracel Corporation, a Delaware corporation (the "Company"), hereby
makes application to immediately withdraw its Registration Statement on Form 8-A
(File No. 000-25363) (the "8-A Registration Statement"), relating to the
Company's securities. The Registrant filed the 8-A Registration Statement on
February 8, 1999, under Section 12(b) and 12(g) of the Securities Exchange Act
of 1934, as amended (the "`34 Act"). This request for withdrawal of the 8-A
Registration Statement is being made because the Company is will not request
effectiveness for its Registration Statement on Form S-1 (File No. 333-58819) by
the date the 8-A Registration Statement would automatically become effective
pursuant to Section 12 of the `34 Act.

        If you have any questions regarding this request for withdrawal, please
call our contact Allen L. Weingarten or Gregory R. Carney of Morrison & Foerster
LLP, counsel to the Company, at (212) 468-8063 and (212) 468-8151, respectively.

                             Sincerely,

                             INTRACEL CORPORATION

                             By:  /s/  Simon R. McKenzie
                                  -------------------------------
                                  Simon R. McKenzie
                                  President and Chief Executive Officer



cc:     John L. Krug, Esq.
        Allen L. Weingarten, Esq.
        Gregory R. Carney, Esq.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission